Table 3 Results of the multiple linear regression model and goodness-of-fit statistics of the different acuity models for the original NEI VFQ-25 composite scores.

From: Impacts of monocular, binocular, and functional visual acuity on vision-related quality of life in patients with type 2 diabetes

Visual acuity

R2

AIC

BIC

Beta (95% CI)

p

Relative change %

All diabetes (n = 90)

Both eyes

0.373

446.6

466.6

− 29.7 (− 40.0 to − 19.5)

< 0.001*

Reference

Better eye

0.321

454.9

474.9

− 25.4 (− 35.6 to − 15.1)

< 0.001*

14.5

FAS-C

0.330

452.4

472.4

-25.0 (− 34.8 to − 15.2)

< 0.001*

15.8

AMA-1

0.308

457.7

477.7

− 21.0 (− 30.6 to − 11.5)

< 0.001*

29.3

AMA-2

0.340

451.1

471.0

− 26.2 (− 36.1 to − 16.3)

< 0.001*

11.8

No-DR diabetes (n = 48)

Both eyes

0.236

202.4

217.4

− 4.2 (− 20.4 to 12.1)

0.626

Reference

Better eye

0.231

202.7

217.7

− 1.4 (− 15.3 to 12.5)

0.860

66.7

FAS-C

0.236

202.5

217.5

− 3.2 (− 16.2 to 09.8)

0.628

23.8

AMA-1

0.233

202.6

217.6

− 2.1 (− 14.4 to 10.2)

0.724

50.0

AMA-2

0.236

202.5

217.5

− 3.4 (− 17.1 to 10.2)

0.625

19.0

DR diabetes (n = 42)

Both eyes

0.536

228.9

242.8

− 39.5 (− 54.8 to − 24.1)

< 0.001*

Reference

Better eye

0.496

232.3

246.2

− 37.3 (− 53.1 to − 21.4)

< 0.001*

5.6

FAS-C

0.454

235.7

249.6

− 33.3 (− 49.0 to − 17.6)

< 0.001*

15.7

AMA-1

0.436

239.8

253.7

− 29.3 (− 45.1 to − 13.4)

< 0.001*

25.8

AMA-2

0.473

234.2

248.1

− 34.8 (− 50.5 to − 19.2)

< 0.001*

11.9

  1. AIC Akaike information criterion, BIC Bayesian information criterion, DR diabetic retinopathy, FVS-C functional acuity score developed by Colenbrander, AMA-1 early version of FAS algorithm developed by the American Medical Association, AMA-2 new version of FAS algorithm developed by the American Medical Association. *Indicates significant p values (p < 0.05).
Back to article page